Search

Bio Roundup: Moderna's IPO, Arena's Comeback, E-Cig Survey & More

BIO ROUNDUP: MODERNA'S IPO, ARENA'S COMEBACK, E-CIG SURVEY & MORE

Thanksgiving is around the corner and this week delivered a bounty of deals that have a number of life science companies expressing...

Bio Roundup: Alzheimer's Puzzle, ESMO Assessed, Drug Prices & More

BIO ROUNDUP: ALZHEIMER'S PUZZLE, ESMO ASSESSED, DRUG PRICES & MORE

In the biotech investment and research communities this week, much of the attention was turned to Europe. Munich, Germany, hosted the...

 
 
 

MIRATI THERAPEUTICS PRESENTS UPDATED POSITIVE CLINICAL DATA FROM SITRAVATINIB IMMUNO-ONCOLOGY COMBINATION TRIAL AT ESMO 2018 CONGRESS AND ANNOUNCES FDA GUIDANCE FOR REGISTRATION TRIAL

Updated analysis from ongoing Phase 2 trial of sitravatinib in combination with nivolumab demonstrated significant clinical activity...

 
 
 
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive's End

BIO ROUNDUP: PRICES ON TV, NOVARTIS HEARTS RADIO, WARP DRIVE'S END

Two new battlegrounds emerged this week in the nation's ongoing drug pricing debate. The first involved television: The federal government...

 
 
 
Bio Roundup: Alnylam's Moment, Read on Rebates, Skinny Plans & More

BIO ROUNDUP: ALNYLAM'S MOMENT, READ ON REBATES, SKINNY PLANS & MORE

Millions of people might be on vacation as we hit the dog days, but drug makers and politicians aren't taking a break from the gamesmanship...

 
 
 
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks

BIO ROUNDUP: CMS BACKS CANCER TESTS, RIGHT TO TRY PASSES, ABBVIE SINKS

We'll start this week's roundup with several stories from Washington, D.C. that could have a lasting effect on public health. The FDA...

HIV breakthrough as cancer drug does wonders for patient

HIV BREAKTHROUGH AS CANCER DRUG DOES WONDERS FOR PATIENT

A 51-year old French man given nivolumab - sold as Opdivo - saw a 'drastic and persistent decrease' in the reservoirs of cells where...

 
 
 
Chemo Tops Pfizer, Merck KGaA Drug in Big Stomach Cancer Test

CHEMO TOPS PFIZER, MERCK KGAA DRUG IN BIG STOMACH CANCER TEST

Pfizer and Merck KGaA's bid to have a stomach cancer treatment that could leapfrog rival immunotherapies has fallen short. The companies...

Roche Gains Ground on Rivals With Drug Combo's Success in Lung Cancer

ROCHE GAINS GROUND ON RIVALS WITH DRUG COMBO'S SUCCESS IN LUNG CANCER

Roche/Genentech reported this morning that its cancer immunotherapy drug, atezolizumab , has succeeded in a clinical study that could...

 
 
 
Five Prime Shares Dive on Latest Hiccup For Cancer Immunotherapy Combos

FIVE PRIME SHARES DIVE ON LATEST HICCUP FOR CANCER IMMUNOTHERAPY COMBOS

Another prospective combination of cancer immunotherapy drugs has shown its warts in clinical testing. The latest example: an experimental...

 
 
 
 
 
 
 
 
 
Prolonged Treatment Increases Life Span of Head and Neck Cancer Patients

PROLONGED TREATMENT INCREASES LIFE SPAN OF HEAD AND NECK CANCER PATIENTS

Continuous use of an immune inhibiting drug called nivolumab aids extended survival of head and neck cancer patients.